NAUT Valuation

Nautilus Biotechnology Inc

Add to Watchlist

Advanced Chart

1.850

+0.52(39.098%)1D

NAUT Relative Valuation

NAUT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NAUT is overvalued; if below, it's undervalued.

Historical Valuation

Nautilus Biotechnology Inc (NAUT) is now in the Fair zone, suggesting that its current forward PS ratio of 1.33 is considered Fairly compared with the five-year average of -6.56. The fair price of Nautilus Biotechnology Inc (NAUT) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：1.85

Fair

-2.13

Trailing

Forward

-1.00

EV/EBITDA

Nautilus Biotechnology Inc. (NAUT) has a current EV/EBITDA of -1.00. The 5-year average EV/EBITDA is -2.63. The thresholds are as follows: Strongly Undervalued below -10.56, Undervalued between -10.56 and -6.59, Fairly Valued between 1.34 and -6.59, Overvalued between 1.34 and 5.30, and Strongly Overvalued above 5.30. The current Forward EV/EBITDA of -1.00 falls within the Historic Trend Line -Fairly Valued range.

-0.93

EV/EBIT

Nautilus Biotechnology Inc. (NAUT) has a current EV/EBIT of -0.93. The 5-year average EV/EBIT is -2.49. The thresholds are as follows: Strongly Undervalued below -10.36, Undervalued between -10.36 and -6.42, Fairly Valued between 1.45 and -6.42, Overvalued between 1.45 and 5.38, and Strongly Overvalued above 5.38. The current Forward EV/EBIT of -0.93 falls within the Historic Trend Line -Fairly Valued range.

1.33

Nautilus Biotechnology Inc. (NAUT) has a current PS of 1.33. The 5-year average PS is 528.54. The thresholds are as follows: Strongly Undervalued below -1752.08, Undervalued between -1752.08 and -611.77, Fairly Valued between 1668.86 and -611.77, Overvalued between 1668.86 and 2809.17, and Strongly Overvalued above 2809.17. The current Forward PS of 1.33 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Nautilus Biotechnology Inc. (NAUT) has a current P/OCF of 0.00. The 5-year average P/OCF is -3.40. The thresholds are as follows: Strongly Undervalued below -12.75, Undervalued between -12.75 and -8.07, Fairly Valued between 1.28 and -8.07, Overvalued between 1.28 and 5.96, and Strongly Overvalued above 5.96. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Nautilus Biotechnology Inc. (NAUT) has a current P/FCF of 0.00. The 5-year average P/FCF is -3.24. The thresholds are as follows: Strongly Undervalued below -12.10, Undervalued between -12.10 and -7.67, Fairly Valued between 1.19 and -7.67, Overvalued between 1.19 and 5.62, and Strongly Overvalued above 5.62. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Nautilus Biotechnology Inc (NAUT) has a current Price-to-Book (P/B) ratio of 0.99. Compared to its 3-year average P/B ratio of 1.06 , the current P/B ratio is approximately -6.10% higher. Relative to its 5-year average P/B ratio of 0.58, the current P/B ratio is about 72.42% higher. Nautilus Biotechnology Inc (NAUT) has a Forward Free Cash Flow (FCF) yield of approximately -0.32%. Compared to its 3-year average FCF yield of -26.41%, the current FCF yield is approximately -98.78% lower. Relative to its 5-year average FCF yield of -20.76% , the current FCF yield is about -98.45% lower.

0.99

P/B

Median3y

1.06

Median5y

0.58

-0.32

FCF Yield

Median3y

-26.41

Median5y

-20.76

Competitors Valuation Multiple

The average P/S ratio for NAUT's competitors is 5.99, providing a benchmark for relative valuation. Nautilus Biotechnology Inc Corp (NAUT) exhibits a P/S ratio of 1.33, which is -77.80% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

NAUT.O

Nautilus Biotechnology Inc

Insight Molecular Diagnostics Inc

Performance Decomposition

Market capitalization of NAUT increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of NAUT in the past 1 year is driven by Unknown.